Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma

SIMPLE SUMMARY: Cancer metastasis to the lung represents the second most common site of metastasis, and a major challenge for clinical treatment of cancer, however, armed oncolytic viruses (Ovs) systemically delivered by carrier leukocytes represents a new treatment strategy. To study PBMC delivery...

Descripción completa

Detalles Bibliográficos
Autores principales: Christie, John D., Appel, Nicole, Zhang, Liqiang, Lowe, Kenneth, Kilbourne, Jacquelyn, Daggett-Vondras, Juliane, Elliott, Natalie, Lucas, Alexandra R., Blattman, Joseph N., Rahman, Masmudur M., McFadden, Grant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773855/
https://www.ncbi.nlm.nih.gov/pubmed/35053501
http://dx.doi.org/10.3390/cancers14020337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773855/
https://www.ncbi.nlm.nih.gov/pubmed/35053501
http://dx.doi.org/10.3390/cancers14020337

Ejemplares similares